Tuesday, September 07, 2021 4:41:07 PM
I have no idea why anyone would be excited about getting current.
The OTCM doesn't place a CE on a company because of delinquent filings - if that was true why wasn't there a CE 2 years ago.
The 52 Week high was $0.0158 - the question becomes how hard will Deitsch pump NPHC.
The patents don't have any value.
The Orphan Drug Designation has no value.
Remember that Deitsch has been pumping NPHC for 19 years - so most investors aren't going to get duped again.
Too many red flags to trade and being long is a very poor investment strategy - some have been holding for 9 years - that was dead money for 9 years.
Deitsch still has too deal with the SEC.
IG
The First Casualty of Emotion is Reason.
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM